| Name | Title | Contact Details |
|---|
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
CBOSS is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Youngstown, OH. To find more information about CBOSS, please visit www.cboss.com
Winchester Convalescent Hosp is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fountain View at Logan Square is a luxury senior living community in Philadelphia that offers breathtaking views and well-appointed apartments. It is the only Continuing Care Retirement Community (CCRC) in Center City Philadelphia.
Cleo is the support system for working families. With its integrated family benefits platform, Cleo combines proactive, expert guidance with an intuitive engagement hub to help connect families with the support they need to be their best at home and at work.